Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The red blood cell (RBC) membrane and its associated cytoskeletal proteins and ion pumps constitute a specialized structural and functional network essential for erythrocyte integrity, shape, and ion homeostasis. This complex includes integral membrane proteins such as Band 3 (Anion exchanger 1) and glycophorins, which are anchored to a flexible sub-membrane cytoskeleton composed of spectrin, actin, and ankyrin (1.2.1, 1.2.2). This arrangement allows RBCs to undergo extreme deformation while traversing narrow capillaries. Ion pumps and channels, such as the Na+/K+-ATPase, Ca2+-ATPase (PMCA4), and the Gardos channel (KCNN4), regulate intracellular ion concentrations and cell volume (1.1.1, 1.3.1). Mutations or damage to these proteins are central to the pathogenesis of hereditary anemias, sickle cell disease, and the host response to malaria (1.2.4, 1.3.5). Pharmacological targeting of these components, such as Gardos channel inhibition by senicapoc, aims to prevent RBC dehydration and hemolysis, while the membrane itself is increasingly explored as a platform for targeted drug delivery (1.3.2, 1.4.5).
Inhibition of the Gardos channel (KCNN4) to prevent potassium and water loss; inhibition of the Na+/K+-ATPase to alter ion gradients; modulation of cytoskeletal-membrane anchoring to improve cell stability; and inhibition of the Ca2+ pump (PMCA) to regulate intracellular calcium levels.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Red blood cell membrane and cytoskeletal proteins and ion pumps (RBC membrane/cytoskeleton/pumps).